GLP-1 drugs like Ozempic may have health benefits, but they come with risks
With with GLP-1 drugs, gastrointestinal issues, such as nausea, vomiting, constipation, and gastroesophageal reflux disease, ...
infectiousdiseaseadvisor.com1d
Herbal Supplement Use in Autoimmune Disease: Balancing Benefits and Risks
Despite the recent rise in herbal supplement use, research suggests certain supplements may pose risks for patients with ...
The Second Trump White House Could Drastically Reshape Infectious Disease Research. Here’s What’s at Stake.
Donald Trump’s pick to lead the federal health agency has vowed to replace hundreds of staffers and shift research away from ...
FierceBiotech4d
AI drug discoverer's antiviral reduces COVID in mouse lungs, neutralizes other RNA viruses
Many of the most devastating infectious diseases are caused by RNA viruses, and Model Medicines is working on one compound to ...
Healio1d
Infectious Disease News
normal conditions in the U.S., a retrospective analysis published in Nature Medicine revealed. Using a novel approach accounting for prescriber preference, researchers found that longer durations ...
HealthDay on MSN1d
Trump Ends Push to Slash Prescription Drug Costs
President Trump has ended a Biden administration effort to lower the cost of prescription drugs for people on Medicare and Medicaid.
Even Adults May Soon Be Vulnerable to ‘Childhood’ Diseases
Outbreaks among the unvaccinated are a predictable consequence of falling immunization rates. But even vaccinated adults may ...
cidrap.umn8d
BARDA to fund development of COVID preventive drug
Shionogi will receive $375 million to develop a long-acting protease inhibitor designed to prevent SARS-CoV-2 infection in ...
No new infectious disease emerges in China recently, said China’s NHC official
A press conference held by National Health Commission of China on January 12, 2025. Photo: CCTV. There's no new infectious ...